# Nuclide record tilmanocept-tc99m (drug). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/drugs/tilmanocept-tc99m/>
  a schema:Drug ;
  nuclide:kind "drug" ;
  schema:identifier "tilmanocept-tc99m" ;
  schema:name "Technetium-99m tilmanocept"@en ;
  schema:description "The purpose-built tracer for sentinel lymph node mapping in breast cancer, melanoma and oral cancer, replacing off-label sulfur colloid."@en ;
  schema:url <https://nuclide.cc/drugs/tilmanocept-tc99m/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Tilmanocept> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Lymphoseek> ;
  nuclide:status "approved" ;
  nuclide:tag "gap-fill", "diagnostic" ;
  nuclide:modality "Radiopharmaceutical lymphatic mapping agent" ;
  schema:alternateName "Lymphoseek" ;
  nuclide:approval "US 2013: Lymphatic mapping with a handheld gamma counter in breast cancer and melanoma", "US 2014: Sentinel lymph node localisation in oral cavity squamous cell carcinoma", "EU 2014: Sentinel node imaging in breast cancer, melanoma, oral SCC" ;
  nuclide:related <https://nuclide.cc/isotopes/tc-99m/> ;
  nuclide:technologies <https://nuclide.cc/technologies/spect/> ;
  nuclide:companies <https://nuclide.cc/companies/navidea/> .